|
Volumn 36, Issue 9, 2004, Pages 2615-2617
|
The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B VACCINE;
HLA A3 ANTIGEN;
ADOLESCENT;
ADULT;
AGED;
ALLELE;
ANTIBODY TITER;
ARTICLE;
CONTROLLED STUDY;
FEMALE;
HEMODIALYSIS;
HEPATITIS B;
HUMAN;
HUMAN TISSUE;
IMMUNOMODULATION;
KIDNEY FAILURE;
KIDNEY GRAFT;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
SEX DIFFERENCE;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
VACCINATION;
ALLELES;
FEMALE;
GENE FREQUENCY;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VACCINES;
HLA-A3 ANTIGEN;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MALE;
VACCINES, SYNTHETIC;
|
EID: 11144289039
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.09.063 Document Type: Article |
Times cited : (5)
|
References (7)
|